ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Randomised phase II trial of irinotecan plus cisplatin vs irinotecan, cisplatin plus etoposide repeated every 3 weeks in patients with extensive-disease small-cell lung cancer
British Journal of Cancer
◽
10.1038/sj.bjc.6604233
◽
2008
◽
Vol 98
(4)
◽
pp. 693-696
◽
Cited By ~ 3
Author(s):
I Sekine
◽
H Nokihara
◽
K Takeda
◽
Y Nishiwaki
◽
K Nakagawa
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Extensive Disease
Download Full-text
Related Documents
Cited By
References
P1-215: Three drug regiment (Irinotecan, Carboplatin and Etoposide) as a front line treatment in extensive disease small-cell lung cancer: phase II trial
Journal of Thoracic Oncology
◽
10.1097/01.jto.0000284313.78584.ac
◽
2007
◽
Vol 2
(8)
◽
pp. S824
Author(s):
Andriani G. Charpidou
◽
Nikolaos Katirtzoglou
◽
Ioannis Gkiozos
◽
Eleni Karapanagiotou
◽
Anna Rigopoulou
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Line Treatment
◽
Front Line
◽
Small Cell Lung
◽
Extensive Disease
Download Full-text
A Weekly Combination of Carboplatin and Irinotecan for Previously Untreated Extensive Disease Small-cell Lung Cancer, Results of a Minimum Follow-up of 3 Years: A Multi-center Phase II Trial JMTO LC02-02
Japanese Journal of Clinical Oncology
◽
10.1093/jjco/hys028
◽
2012
◽
Vol 42
(5)
◽
pp. 387-393
◽
Cited By ~ 4
Author(s):
K. Okishio
◽
T. Mio
◽
M. Kawahara
◽
H. Yoshioka
◽
K. Yanagihara
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Extensive Disease
Download Full-text
Irinotecan and etoposide for previously untreated extensive-disease small cell lung cancer: A phase II trial of West Japan Thoracic Oncology Group
Lung Cancer
◽
10.1016/j.lungcan.2005.01.005
◽
2005
◽
Vol 49
(2)
◽
pp. 263-269
◽
Cited By ~ 7
Author(s):
S. Kudoh
◽
S. Nakamura
◽
T. Nakano
◽
K. Komuta
◽
T. Isobe
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Oncology Group
◽
Small Cell Lung
◽
Extensive Disease
Download Full-text
P-558 Phase-II trial of topotecan and etoposide in extensive disease small cell lung cancer (ED-SCLC)
Lung Cancer
◽
10.1016/s0169-5002(03)92525-6
◽
2003
◽
Vol 41
◽
pp. S232
Author(s):
Martin Reck
◽
Erika Buchholz
◽
Gesine Groth
◽
Sabine Kaubitzsch
◽
Ulrich Gatzemeier
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Extensive Disease
Download Full-text
69P Combining sintilimab with anlotinib as second-line or later therapy in patients with extensive-disease small cell lung cancer: A prospective, single-arm, phase II trial
Annals of Oncology
◽
10.1016/j.annonc.2021.10.087
◽
2021
◽
Vol 32
◽
pp. S1402
Author(s):
M. Shuxiang
◽
H. Zhen
◽
W. Lili
◽
W. Yufeng
◽
Y. Sen
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Second Line
◽
Small Cell Lung
◽
Extensive Disease
Download Full-text
A phase II trial of fractionated irinotecan plus carboplatin for previously untreated extensive-disease small cell lung cancer
Lung Cancer
◽
10.1016/j.lungcan.2006.08.014
◽
2006
◽
Vol 54
(3)
◽
pp. 365-370
◽
Cited By ~ 15
Author(s):
Joo Hyuk Sohn
◽
Hye Jin Choi
◽
Joon Chang
◽
Se Kyu Kim
◽
Chang Geal Lee
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Extensive Disease
Download Full-text
Irinotecan plus carboplatin versus etoposide plus carboplatin in extensive disease small cell lung cancer: A randomized phase II trial
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.7046
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 7046-7046
◽
Cited By ~ 1
Author(s):
A. Schmittel
◽
L. Fischer von Weikersthal
◽
M. Sebastian
◽
H. Link
◽
K. Schulze
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Extensive Disease
◽
Randomized Phase Ii
Download Full-text
A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-006-0336-0
◽
2007
◽
Vol 60
(1)
◽
pp. 1-6
◽
Cited By ~ 3
Author(s):
Masahiro Tabata
◽
Katsuyuki Kiura
◽
Niro Okimoto
◽
Yoshihiko Segawa
◽
Tetsu Shinkai
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Extensive Disease
Download Full-text
1134 POSTER A randomized phase II trial of irinotecan plus carboplatin versus etoposide plus carboplatin in patients with extensive disease small cell lung cancer
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(05)81428-4
◽
2005
◽
Vol 3
(2)
◽
pp. 327-328
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
◽
Extensive Disease
◽
Randomized Phase Ii
Download Full-text
Phase II Trial of Thalidomide, Irinotecan and Gemcitabine in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer
Cancer Investigation
◽
10.1080/07357900801944856
◽
2009
◽
pp. 1-1
Author(s):
A. R. Jazieh
◽
R. Komrokji
◽
A. Gupta
◽
S. Patil
◽
D. Flora
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Trial
◽
Small Cell
◽
Small Cell Lung
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close